NWAPX
Price
$38.83
Change
-$0.26 (-0.67%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

NWAPX vs RMFCX

Header iconNWAPX vs RMFCX Comparison
Open Charts NWAPX vs RMFCXBanner chart's image
Nationwide BNY Mellon Dyn US Eq Inc Egl
Price$38.83
Change-$0.26 (-0.67%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
NWAPX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NWAPX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWAPX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. NWAPX (632M). NWAPX (1.71) and RMFCX (1.69) have matching dividends . NWAPX was incepted earlier than RMFCX: NWAPX (5 years) vs RMFCX (23 years). NWAPX is a more actively managed with annual turnover of: 76.61 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than NWAPX: RMFCX (250) vs NWAPX (50000). NWAPX annual gain was more profitable for investors over the last year : 15.46 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. NWAPX (24.81).
NWAPXRMFCXNWAPX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years23 years-
Gain YTD17.06611.423149%
Front LoadN/AN/A-
Min. Initial Investment5000025020,000%
Min. Initial Investment IRAN/AN/A-
Net Assets632M104B1%
Annual Yield % from dividends1.711.69101%
Returns for 1 year15.4612.63122%
Returns for 3 years-3.2814.16-23%
Returns for 5 years24.8140.3961%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc